Regulatory Network in Protein Phosphorylation
[Home] [About] [Browse Kinome] [Phosphorylation Prediction] [Expression Analysis] [Statistics] [Help] Version 1.0

[Back to Kinase CK2al-rs]
Substrate: RELA

Description: Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit).

Synonyms: NFKB3

Ensembl ID: ENSG00000173039

UniprotKB/SwissProt: TF65_HUMAN (Q04206)

Function: p65 is a subunit of the nuclear factor kappa-B, a second messenger, which activates the transcription of a number of genes in multiple tissues. The inhibitory effect of I-kappa-B upon NF- kappa-B in the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).
PDB:1NFI
Protein Domain and Phosphorylation Sites:

The phosphorylated sites of RELA

No.SubstrateUniProtKB IDPositionPhosphoPeptideSolvent AccessibilityCatalytic kinaseSourceComputational Annotation of Catalytic KinaseInteracting PartnersExpression Analysis
1RELATF65_HUMANT254AIVFR T PPYAD 19.70% Phospho.ELM 7.0View   
2RELATF65_HUMANS276QLRRP S DRELS 47.70%MSK2 Swiss-Prot 55.0   ViewAnalyzing
3RELATF65_HUMANS276QLRRP S DRELS 47.70%MSK1 Swiss-Prot 55.0   ViewAnalyzing
4RELATF65_HUMANS276QLRRP S DRELS 47.70%PKACa HPRD:01241(in vitro;in vivo)  ViewAnalyzing
5RELATF65_HUMANS276QLRRP S DRELS 47.70%MSK1(RSK5) Phospho.ELM 7.0 ViewAnalyzing
6RELATF65_HUMANS311YETFK S IMKKS 24.59%PKCz HPRD:01241(in vitro;in vivo)  ViewAnalyzing
7RELATF65_HUMANS311YETFK S IMKKS 24.59%PKCz(PKC zeta) Phospho.ELM 7.0 ViewAnalyzing
8RELATF65_HUMANT435QAGEG T LSEAL 23.86%Erk2(MAPK1) Phospho.ELM 7.0 ViewAnalyzing
9RELATF65_HUMANS468FTDLA S VDNSE 36.98%GSK3B(GSK3 beta) Phospho.ELM 7.0 ViewAnalyzing
10RELATF65_HUMANT505ITRLV T GAQRP 31.24% Phospho.ELM 7.0View   
11RELATF65_HUMANS529PNGLL S GDEDF 49.60%CK2_group Phospho.ELM 7.0 ViewAnalyzing
12RELATF65_HUMANS529PNGLL S GDEDF 49.60%CK2a1(CK2 alpha) Phospho.ELM 7.0 ViewAnalyzing
13RELATF65_HUMANS536DEDFS S IADMD 23.07%p38a(MAPK14) Phospho.ELM 7.0 ViewAnalyzing
14RELATF65_HUMANS536DEDFS S IADMD 23.07%IKKa(IKK alpha) Phospho.ELM 7.0 ViewAnalyzing
15RELATF65_HUMANS536DEDFS S IADMD 23.07%IKKb(IKK beta) Phospho.ELM 7.0 ViewAnalyzing
16RELATF65_HUMANS536DEDFS S IADMD 23.07%TBK1 Phospho.ELM 7.0  ViewAnalyzing
17RELATF65_HUMANS536DEDFS S IADMD 23.07%IKKa HPRD:01241(in vivo)  ViewAnalyzing
18RELATF65_HUMANS536DEDFS S IADMD 23.07%IKKe(IKK epsilon) Phospho.ELM 7.0 ViewAnalyzing
19RELATF65_HUMANS536DEDFS S IADMD 23.07%IKK_group Phospho.ELM 7.0 ViewAnalyzing
20RELATF65_HUMANS543ADMDF S ALLSQ 17.47%CK2a1-rs HPRD:01241(in vitro)  ViewAnalyzing
21RELATF65_HUMANS543ADMDF S ALLSQ 17.47%CK2a1 HPRD:01241(in vitro)  ViewAnalyzing